Concepedia

Author

Stéphanie Dulucq

InsermORCID

Also Known As

Dulucq, Stéphanie, S Dulucq, S. Dulucq, Stephanie Dulucq, Stéphanie Dulucq, Stéphanie Dulucq

121

Publications

2.2K

Citations

23

H-Index

45

Concepts

All Affiliations

InsermInstitut BergoniéCentre Hospitalier Universitaire de BordeauxHôpital Saint-LouisCentre Léon Bérard
SD

About

Stéphanie Dulucq is an author at Inserm specializing in medicine, hematology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

283

2

Health Sciences

5

5

103

3

Engineering

1

1

60

4

Public Health

1

1

57

5

Blood Transplantation

1

1

27

Stéphanie Dulucq

×

36

Publications

1.6K

Citations

20

H-Index

YearCitations

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

Stéphanie Dulucq, Stéphane Bouchet, Béatrice Turcq,

Blood

2008

233

Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients

Franck E. Nicolini, Stéphanie Dulucq, Lisa Boureau,

Clinical Cancer Research

2019

108

Quantitative phosphoproteomics revealed interplay between Syk and Lyn in the resistance to nilotinib in chronic myeloid leukemia cells

Romain Gioia, Cédric Leroy, Claire Drullion,

Blood

2011

99

DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL

Stéphanie Dulucq, Geneviève St‐Onge, Vincent Gagné,

Blood

2007

97

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

Helen White, Liesbet Deprez, Philippe Corbisier,

Leukemia

2014

81

Characterization and Clinical Significance of Hemolysis After Pulsed Field Ablation for Atrial Fibrillation: Results of a Multicenter Analysis

Miruna Popa, Sandrine Venier, Roberto Menè,

Circulation Arrhythmia and Electrophysiology

2024

75

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group

Delphine Réa, Shanti Amé, Marc Berger,

Cancer

2018

72

Preliminary Report Of The STIM2 Study: A Multicenter Stop Imatinib Trial For Chronic Phase Chronic Myeloid Leukemia De Novo Patients On Imatinib

François‐Xavier Mahon, Franck E. Nicolini, Marie‐Pierre Noël,

Blood

2013

61

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy

Gabriel Étienne, Stéphanie Dulucq, Franck E. Nicolini,

Haematologica

2013

60

Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

Nicholas C.P. Cross, Helen White, Thomas Ernst,

Leukemia

2016

58

Page 1